Effects of baseline lactate dehydrogenase (LDH), interferon gamma (IFN-g) expression, and tumor mutational burden (TMB) on treatment response to first-line atezolizumab (A) plus vemurafenib (V) and cobimetinib (C) in BRAF(V600) mutation-positive advanced melanoma.

Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/45729

Title:	Effects of baseline lactate dehydrogenase (LDH), interferon gamma (IFN-g) expression, and tumor mutational burden (TMB) on treatment response to first-line atezolizumab (A) plus vemurafenib (V) and cobimetinib (C) in BRAF(V600) mutation-positive advanced melanoma.
Authors:	ROBERT, Caroline; LEWIS, Karl D.; ASCIERTO, Paolo Antonio; MUNHOZ, Rodrigo Ramella; LISZKAY, Gabriella; CRUZ-MERINO, Luis de la; OLAH, Judit; QUEIROLO, Paola; MACKIEWICZ, Jacek; CARO, Ivor; SHAH, Kalpit; FORBES, Harper; LI, Haocheng; HERTIG, Christian; YAN, Yibing; MCKENNA, Edward Francis; GUTZMER, Ralf; MCARTHUR, Grant A.
Citation:	JOURNAL OF CLINICAL ONCOLOGY, v.39, n.15, suppl.S, 2021
Appears in Collections:	Comunicações em Eventos - HC/ICESP Instituto do Câncer do Estado de São Paulo - HC/ICESP Comunicações em Eventos - LIM/24 LIM/24 - Laboratório de Oncologia Experimental

Files in This Item:

There are no files associated with this item.